10X Genomics, Inc. (TXG)

64.56 +0.76 (+1.18%) USD  |  NASDAQ  |  Aug 25, 14:54
More

10X Genomics EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for TXG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 10, 2026 --
August 07, 2026 --
July 13, 2026 --
June 05, 2026 --
May 11, 2026 --
May 08, 2026 --
April 20, 2026 --
March 30, 2026 --
March 02, 2026 --
February 13, 2026 --
January 12, 2026 --
December 22, 2025 --
November 07, 2025 --
August 11, 2025 --
Date Value
August 08, 2025 --
July 01, 2025 --
May 12, 2025 --
May 09, 2025 --
February 13, 2025 --
January 13, 2025 --
October 30, 2024 --
October 10, 2024 --
August 09, 2024 --
July 23, 2024 --
July 16, 2024 --
June 04, 2024 --
May 01, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Twist Bioscience Corp. Upgrade
Alamar Biosciences, Inc. (California) Upgrade
Personalis, Inc. Upgrade
Adaptive Biotechnologies Corp. Upgrade
Champions Oncology, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade